Brainstorm Cell Therapeutics Inc.
BCLI
$0.61
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -99.39% | -49.88% | 779.14% | 11.31% | -95.16% |
| Total Receivables | -24.53% | 58.21% | 6.35% | 57.50% | 21.21% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -27.69% | -5.80% | 360.00% | -13.46% | -50.32% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -66.47% | -35.03% | 505.71% | 5.77% | -90.46% |
|
|
|||||
| Total Current Assets | -66.47% | -35.03% | 505.71% | 5.77% | -90.46% |
| Net Property, Plant & Equipment | -25.30% | -20.19% | -16.60% | -14.88% | -12.59% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 13.33% | 10.29% | -0.97% | 1.48% | 2.01% |
| Total Assets | -46.22% | -28.14% | 94.92% | -9.53% | -64.37% |
|
|
|||||
| Total Accounts Payable | 7.05% | -11.77% | 11.79% | 32.09% | -13.80% |
| Total Accrued Expenses | -4.63% | -31.78% | -13.09% | -28.44% | 20.47% |
| Short-term Debt | 0.00% | -91.58% | 300.00% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -27.56% | -14.00% | -19.31% | -3.68% | 0.71% |
| Total Finance Division Other Current Liabilities | 11.53% | -12.53% | 34.48% | 36.97% | -2.16% |
| Total Other Current Liabilities | 11.53% | -12.53% | 34.48% | 36.97% | -2.16% |
| Total Current Liabilities | 5.80% | -21.77% | 21.42% | 26.77% | -7.92% |
|
|
|||||
| Total Current Liabilities | 5.80% | -21.77% | 21.42% | 26.77% | -7.92% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 0.00% | -91.58% | 300.00% | -- | -- |
| Capital Leases | -47.37% | -25.20% | -25.73% | -36.90% | -31.57% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -38.68% | -35.08% |
| Total Liabilities | 5.22% | -21.81% | 14.92% | 18.73% | -12.25% |
|
|
|||||
| Common Stock & APIC | 0.21% | 1.94% | 1.45% | 0.58% | 0.08% |
| Retained Earnings | -0.91% | -1.26% | -1.26% | -1.33% | -1.23% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -27.01% | 18.77% | 3.95% | -28.18% | -71.73% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -27.01% | 18.77% | 3.95% | -28.18% | -71.73% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -27.01% | 18.77% | 3.95% | -28.18% | -71.73% |
|
|
|||||